Rob C. Lufkin

Oncology | Hematology

5050 Northeast Hoyt Street
Portland, OR 97213

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1 publications

Durable responses and reversible toxicity of high-dose interleukin-2 treatment of melanoma and renal cancer in a Community Hospital Biotherapy Program.

Durable responses and reversible toxicity of high-dose interleukin-2 treatment of melanoma and renal cancer in a Community Hospital Biotherapy Program.

Journal: Journal for immunotherapy of cancer

Published: January 29, 2014

Showing 1-1 of 1

Last Updated: 09/26/2026